Bollard Group LLC Grows Position in Abbott Laboratories (NYSE:ABT)

Bollard Group LLC increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 97,911 shares of the healthcare product maker’s stock after buying an additional 5,638 shares during the quarter. Bollard Group […]

Related Keywords

Canada , Roberte Funck , Lisad Earnhardt , Raymond James , Signature Resources Capital Management , Abbott Laboratories , Goldman Sachs Group , Wealth Management Group , Citigroup , Bollard Group , Rise Advisors , Cornerstone Planning Group , Royal Bank , Stuart Chaussee Associates Inc , Securities Exchange Commission , Free Report , Resources Capital Management , Planning Group , Private Wealth Management Group , Get Free Report , Established Pharmaceutical Products , Diagnostic Products , Nutritional Products , Abbott Laboratories Daily ,